Human CD20 Monoclonal Antibody, Endotoxin 0.05 EU/mg
Product Sizes
5 mg
£1617.00
YR0131-5MG
20 mg
£3183.00
YR0131-20MG
About this Product
- SKU:
- YR0131
- Additional Names:
- B1|Bp35|CD20|CVID5|FMC7|LEU-16|MS4A1|S7
- Application:
- Block/Inhibit/Neutralise, Cell-based/Functional Assay, ELISA
- Clonality:
- Monoclonal
- Extra Details:
- Obinutuzumab is an antineoplastic CD20 antibody used to treat untreated chronic lymphocytic leukemia in combination with chlorambucil.In contrast to rituximab, which is a classic type I CD20 antibody, obinutuzumab binds to type II CD20 antibodies. This allows obinutuzumab to have a much higher induction of antibody-dependant cytotoxicity and a higher direct cytotoxic effect than the classic CD20 antibodies.
- Formulation:
- Purified from cell culture supernatant in an animal-free facility
- Immunogen:
- Human CD20
- Isotype:
- IgG1, kappa
- Molecular Weight:
- 150 kDa
- Purity:
- >95%
- Shipping Conditions:
- Blue Ice
- Storage Conditions:
- 2-8[o]C Avoid freeze/thaw cycles., -70[o]C Avoid freeze/thaw cycles.
- Supplier:
- ABclonal Technology
- Type:
- Antibody: Biosimilar Antibody
- Manufacturer's Data Sheet:YR0131
